Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 1/20 | 0.55 |
| ▸ | ACR | P10323 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | XBP1 | P17861 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | KIF11 | P52732 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | RXRA | P19793 | 1/20 | 0.44 |
| ▸ | RXRB | P28702 | 1/20 | 0.44 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL2733405 | 0.89 | PRSS1 (0.48) | PRSS1ACRSMN1; SMN2HPGDXBP1 | |
| SCHEMBL236821 | 0.83 | SMN1; SMN2 (0.56) | PRSS1ACRSMN1; SMN2HPGDXBP1 | |
| SCHEMBL6284986 | 0.82 | KMT2A (0.64) | PRSS1SMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL28097833 | 0.81 | PRSS1 (0.50) | PRSS1ACRSMN1; SMN2HPGDXBP1 | |
| SCHEMBL1714626 | 0.81 | LMNA (0.59) | PRSS1ACRSMN1; SMN2HPGDXBP1 | |
| SCHEMBL5699582 | 0.81 | SMN1; SMN2 (0.54) | PRSS1ACRSMN1; SMN2HPGDXBP1 | |
| SCHEMBL5933001 | 0.81 | SMN1; SMN2 (0.54) | PRSS1ACRSMN1; SMN2HPGDXBP1 | |
| SCHEMBL20472709 | 0.80 | SMN1; SMN2 (0.50) | PRSS1ACRSMN1; SMN2HPGDXBP1 | |
| SCHEMBL28280156 | 0.80 | KMT2A (0.44) | PRSS1ACRSMN1; SMN2HPGDXBP1 | |
| SCHEMBL9360100 | 0.80 | PRSS1 (0.49) | PRSS1ACRSMN1; SMN2HPGDXBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5580596-A | MIXTURE OF RAPE OIL METHYLESTER AND MEDIUM AND LONG-CHAIN ALCOHOLS | CPC INTERNATIONAL INC. (US) | 1996-12-03 | — | — | US | claimed |
| EP-4447683-B1 | USE OF ISOXAZOLINECARBOXAMIDE FOR SPROUT INHIBITION | BAYER AG (DE) | 2025-08-13 | — | — | EP | disclosed |
| US-20250057164-A1 | USE OF ISOXAZOLINECARBOXAMIDE FOR SPROUT INHIBITION | BAYER AG (DE) | 2025-02-20 | — | — | US | disclosed |
| WO-2023110813-A1 | USE OF ISOXAZOLINECARBOXAMIDE FOR SPROUT INHIBITION | BAYER AKTIENGESELLSCHAFT (DE) | 2023-06-22 | — | — | WO | disclosed |
| WO-2019237919-A1 | POLYNUCLEOTIDE AND METHOD FOR CONTROLLING INSECT INFESTATION | 北京大北农生物技术有限公司 | 2019-12-19 | — | — | WO | disclosed |
| WO-2019237918-A1 | POLYNUCLEOTIDE AND METHOD USED FOR CONTROLLING INSECT INVASION | 北京大北农生物技术有限公司 | 2019-12-19 | — | — | WO | disclosed |
| WO-2019228151-A1 | POLYNUCLEOTIDE AND METHOD FOR CONTROLLING INSECT INVASION | 北京大北农生物技术有限公司 (CN) | 2019-12-05 | — | — | WO | disclosed |
| EP-2755949-B1 | FUNGICIDAL 4-SUBSTITUTED-3-{PHENYL[(HETEROCYCLYLMETHOXY)IMINO]METHYL}-1,2,4-OXADIZOL-5(4H)-ONE DERIVATIVES | BAYER IP GMBH (DE) | 2015-10-21 | — | — | EP | disclosed |
| US-9090600-B2 | Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4H)-one derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-07-28 | — | — | US | disclosed |
| US-20140349848-A1 | FUNGICIDAL 4-SUBSTITUTED-3--1,2,4-OXADIZOL-5(4H)-ONE DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-11-27 | — | — | US | disclosed |
| US-6710017-B2 | Compositions and methods for controlling algae in recirculating water systems | AVECIA, INC. | 2004-03-23 | — | — | US | disclosed |
| EP-0653912-B1 | SPROUT INHIBITOR FOR POTATOES | PFANNI WERKE GMBH & CO KOMMAND (DE) | 1999-10-06 | — | — | EP | disclosed |
| US-5580596-A | MIXTURE OF RAPE OIL METHYLESTER AND MEDIUM AND LONG-CHAIN ALCOHOLS | CPC INTERNATIONAL INC. (US) | 1996-12-03 | — | — | US | disclosed |
| EP-0311632-B1 | SURFACE ACTIVE LACTAMS | ISP INVESTMENTS INC (US) | 1996-05-29 | — | — | EP | disclosed |
| EP-0653912-A1 | SPROUT INHIBITOR FOR POTATOES | Pfanni Werke GmbH & Co. Kommanditgesellschaft (DE) | 1995-05-24 | — | — | EP | disclosed |
| WO-1994028716-A2 | SPROUT INHIBITOR FOR POTATOES | PFANNI-WERKE GMBH & CO. KG (DE) | 1994-12-22 | — | — | WO | disclosed |
| US-5294644-A | Nonionic surfactants for solubility | ISP INVESTMENTS INC. (US) | 1994-03-15 | — | — | US | disclosed |
| EP-0311632-A4 | SURFACE ACTIVE LACTAMS | — | 1990-12-27 | — | — | EP | disclosed |
| EP-0311632-A1 | SURFACE ACTIVE LACTAMS. | GAF CORP (US) | 1989-04-19 | — | — | EP | disclosed |
| WO-1988000184-A1 | SURFACE ACTIVE LACTAMS | GAF CORPORATION (US) | 1988-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250057164-A1 | USE OF ISOXAZOLINECARBOXAMIDE FOR SPROUT INHIBITION | API5, ING2, CDK5 | PRSS1 4411/4885ACR 4768/4885SMN1; SMN2 3043/4885 |
| US-20140349848-A1 | FUNGICIDAL 4-SUBSTITUTED-3--1,2,4-OXADIZOL-5(4H)-ONE DERIVATIVES | CYP4X1, CYP4B1, CYP4Z1 | PRSS1 3156/4885ACR 472/4885SMN1; SMN2 1570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.